You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 28, 2024

Litigation Details for ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED v. PRINSTON PHARMACEUTICAL INC. (D.N.J. 2017)


✉ Email this page to a colleague

« Back to Dashboard


Small Molecule Drugs cited in ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED v. PRINSTON PHARMACEUTICAL INC.
The small molecule drug covered by the patents cited in this case is ⤷  Try a Trial .

Details for ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED v. PRINSTON PHARMACEUTICAL INC. (D.N.J. 2017)

Date Filed Document No. Description Snippet Link To Document
2017-10-31 1 United States Patent Nos. 8,481,598 (“the ’598 patent”), 8,865,937 (“the ’937 patent”), and RE43,879… infringed United States Patent Nos. 8,481,598, 8,865,937, and RE43,879 by submitting ANDA…products before United States Patent Nos. 8,481,598 and RE43,879 expire, would …expiration date of United States Patent Nos. 8,481,598, 8,865,937, and RE43,879, including any …Page 16 of 19 PageID: 16 States Patent Nos. 8,481,598, 8,865,937, and RE43,879 expire, including External link to document
2021-06-08 455 Opinion the three asserted patents: United States Patents No. 8,481,598 (the “’598 Patent”) and No. RE43, 879… Legal Standard A patent claim is that “portion of the patent document that defines the scope…of levomilnacipran.” ’598 Patent at 11:38–39 (emphasis added). The patent defines the terms “effective…Rather, a POSA reading the patent as a whole would understand that the patent is directed at administering…which is how the ’598 Patent refers to the dosage amounts. See, e.g., ’598 Patent at 3:11–13, 3:17–19, External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.